Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck & Co. continues to develop farnesyl protein transferase inhibitors

Feb. 4, 1997

Preclinical results indicate potential of new approach to treatment of solid tumors

Feb. 3, 1997

Memorial Sloan-Kettering and Sequana form cancer joint venture

Feb. 3, 1997

Chiron/Baxter collaboration for novel cell therapy product for leukemia

Jan. 31, 1997

Potent antitumor agents from Takeda

Jan. 31, 1997

SKB reports novel camptothecin analogues

Jan. 30, 1997

Angiogenesis inhibitor induces dormancy in tumors

Jan. 29, 1997

Licenses offered for antibodies for treatment or diagnosis of breast cancer

Jan. 29, 1997

Invention related to melanoma antigens available for licensing

Jan. 29, 1997

NIH seeks licensees for T-cell receptor technologies

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...